Postencephalitic Parkinsonism: Unique Pathological and Clinical Features-Preliminary Data.

Lewy bodies Parkinson’s disease cognitive disturbances iron pathology neurofibrillary tangles postencephalitic parkinsonism tau protein α-synuclein

Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
10 Sep 2024
Historique:
received: 09 07 2024
revised: 29 08 2024
accepted: 04 09 2024
medline: 27 9 2024
pubmed: 27 9 2024
entrez: 27 9 2024
Statut: epublish

Résumé

Postencephalitic parkinsonism (PEP) is suggested to show a virus-induced pathology, which is different from classical idiopathic Parkinson's disease (PD) as there is no α-synuclein/Lewy body pathology. However, PEP shows a typical clinical representation of motor disturbances. In addition, compared to PD, there is no iron-induced pathology. The aim of this preliminary study was to compare PEP with PD regarding iron-induced pathology, using histochemistry methods on paraffin-embedded post-mortem brain tissue. In the PEP group, iron was not seen, except for one case with sparse perivascular depositions. Rather, PEP offers a pathology related to tau-protein/neurofibrillary tangles, with mild to moderate memory deficits only. It is assumed that this virus-induced pathology is due to immunological dysfunctions causing (neuro)inflammation-induced neuronal network disturbances as events that trigger clinical parkinsonism. The absence of iron deposits implies that PEP cannot be treated with iron chelators. The therapy with L-Dopa is also not an option, as L-Dopa only leads to an initial slight improvement in symptoms in isolated cases.

Identifiants

pubmed: 39329695
pii: cells13181511
doi: 10.3390/cells13181511
pii:
doi:

Substances chimiques

Iron E1UOL152H7
tau Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Sabrina Strobel (S)

Institute of Pathology, Department of Neuropathology, University of Wuerzburg, 97080 Wuerzburg, Germany.

Jeswinder Sian-Hulsmann (J)

Department of Medical Physiology, University of Nairobi, P.O. Box 30197, Nairobi 00100, Kenya.

Dennis Tappe (D)

Bernhard Nocht Institute for Tropical Medicine, 20359 Hamburg, Germany.

Kurt Jellinger (K)

Institute of Clinical Neurobiology, A-1150 Vienna, Austria.

Peter Riederer (P)

Clinic and Policlinic for Psychiatry, Psychosomatics and Psychotherapy, University Hospital Wuerzburg, 97080 Wuerzburg, Germany.
Department of Psychiatry, University of Southern Denmark, 5000 Odense, Denmark.

Camelia-Maria Monoranu (CM)

Institute of Pathology, Department of Neuropathology, University of Wuerzburg, 97080 Wuerzburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH